The market for Complementary and Alternative Medicine for Anti-Aging & Longevity was US$ 44.6 Billion in 2021, and it is expected to grow at a CAGR of 24.4% from 2022 to 2032.
The market for complementary and alternative medicine (CAM) for anti-ageing and & longevity will be driven by the growing ageing population and diseases linked with it. The Complementary and Alternative Medicine for Anti-Aging & Longevity Market accounted for an absolute dollar opportunity of nearly US$ 347.7 Billion from 2022 to 2032.
Attributes | Details |
---|---|
Global Complementary and Alternative Medicine for Anti-Aging & Longevity (2022) | US$ 44.6 Billion |
Global Complementary and Alternative Medicine for Anti-Aging & Longevity (2032) | US$ 347.7 Billion |
Global Complementary and Alternative Medicine for Anti-Aging & Longevity CAGR (2022 to 2032) | 24.4% |
USA Complementary and Alternative Medicine for Anti-Aging & Longevity (2032) | 24.9% |
Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Complementary and Alternative Medicine for Anti-Aging & Longevity Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Complementary and Alternative Medicine for Anti-Aging & Longevity increased at around 20.9% CAGR.
The Complementary and Alternative Medicine for Anti-Aging & Longevity Market is projected to grow at a CAGR of 24.4% over the coming ten years.
The market is expected to grow in the coming years as a result of the changing regulatory landscape and strong government initiatives, which have led to the establishment of strong transnational links across therapeutic paths that connect global, national, and local alternative medicine groups. Furthermore, government activities examining standards relating to the right to health in all of its manifestations are expected to bolster consumers' participation and service providers in the field of CAM. Government actions, such as increased targeted spending, the establishment of government facilities, and the publication of guidelines to ensure the use of complementary and alternative medicine, all help to drive demand for integrative health and complementary medicine practices (CAM).
Medical tourism, which attracts people from all over the world and allows them to seek world-class alternative medical care, is also being promoted by regulatory organizations. In some Indian states, for example, regulatory authorities have invested significantly in the creation and standardization of alternative medical services. A government entity named the Ministry of Ayush has been established to oversee Yoga, Ayurveda, homeopathic, and naturopathy instruction, product creation, research, and other services in India.
Furthermore, in the next years, research focusing on the utilization of traditional medications for the treatment of COVID-19 patients is expected to gain pace. Traditional COVID-19 therapy alternatives are being supported by governments all around the world, but they must meet the same research standards as all other pharmacological choices. This is consequently having a positive ripple effect on complementary and alternative medicine for the anti-aging & longevity market.
In 2020, Europe dominated the global market, accounting for nearly 30% of total sales. In Europe, complementary and alternative medicine (CAM) has become significantly popular and well-accepted. Chiropractic, massage, homeopathy, reflexology, acupuncture, and herbal medicine are the most often used CAM therapies in Europe.
Women and people in their middle years are more likely to use complementary and alternative medicine (CAM). Musculoskeletal issues are the most common conditions addressed with complementary and alternative medicine (CAM) in terms of health determinants. Depression, severe headaches, back issues, stomach or intestinal diseases, and sleeplessness are the most common conditions linked to the use of complementary and alternative medicine.
Furthermore, Ayurveda is gaining popularity in several European countries, with Germany serving as the epicenter of Ayurveda and leading the way in the region, with Austria and Switzerland following suit. EUAA is a federation of educational institutions, Ayurvedic organizations, manufacturers, hospitals, distributors, therapists, and suppliers. The EUAA is a non-profit organization that represents 16 European Economic Area countries and institutions. The mission of the organization is to promote Ayurveda as a holistic medicine throughout the region.
Over the projected period, the market in the Middle East and Africa is expected to expand at the fastest pace. The long history of adopting spiritual approaches as well as herbal remedies to cure various ailments is projected to drive the regional market throughout the forecast period. In the coming years, Qatar is expected to be the region's fastest-growing market for mind-body therapies.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In 2020, the traditional alternative medicine or Traditional Alternative Medicine/Botanicals segment accounted for more than 30% of complementary and alternative medicine for anti-aging & longevity sales. Key players have been investing in CAM therapies since the regulatory rules for starting a business in this industry are less strict than for pharmaceutical enterprises. Government actions meanwhile, boost entrepreneur activity in the CAM domain.
Tai Chi is a type of relaxation exercise that assists older adults, especially those with Parkinson's disease, improve their stability, balance, and flexibility. According to a study released in 2021, in older people, the aggregate cerebral vascular hemodynamic index who practiced Tai Chi was similar to that of the young population and showed a substantial improvement when compared to older adults who did not practice Tai Chi.
The segment growth is being boosted by technological breakthroughs in sensory healing. HUSO, for example, is a sound therapy system that uses acupuncture meridians to control and harmonize the body, as well as a tone to cope with stress and harmful electromagnetic fields. Headphones and wrist and ankle padding are included in the product.
Consumer awareness about the benefits of complementary and alternative medicine goods is expected to grow, as is the adoption of innovative sensory healing technology in hospitals and clinics. However, as western medicine becomes more involved in the anti-aging and longevity business, the sector's expansion will be constrained.
Since several emerging economies perceive CAM products for antiaging and lifespan to be expensive and undercut the need for them, HNWs represent a lucrative consumer pool for complementary and alternative medicine for anti-aging & longevity. Individuals with high net worth in industrialized countries are more inclined than those in poor countries to spend money on complementary and alternative medicine for antiaging and longevity. The low opportunity cost and high social presence are the reasons behind this.
The global market is significantly competitive due to the existence of several companies. Key players focus on growth strategies such as improvement of existing technology, geographic expansion, product launch, and product approval to gain higher market share. Various development strategies help raise consumer awareness of new processes and products, such as product launches and collaborations.
The key players in the global Complementary and Alternative Medicine for Anti-Aging & Longevity market are Anadolu Medical Center, Sinomedica, Acupuncture Enfants, and Ayurveda Kuwait.
Some of the recent developments in complementary and alternative medicine for the anti-aging & longevity market are:
The global Complementary and Alternative Medicine for Anti-Aging & Longevity market size was estimated at US$ 36.5 Billion in 2021 and is estimated to grow further to US$ 44.6 Billion in 2022.
The value of Complementary and Alternative Medicine for the Anti-Aging & Longevity Market is projected to increase at a CAGR of around 24.4% from 2022 to 2032.
The value of Complementary and Alternative Medicine for the Anti-Aging & Longevity Market increased at a CAGR of around 20.9% from 2017 to 2021.
The market for complementary and alternative medicine (CAM) for antiaging and lifespan will be driven by the growing aging population and diseases linked with it.
The top 5 countries driving demand for the Complementary and Alternative Medicine for Anti-Aging & Longevity Market are the USA, China, Japan, the United Kingdom, and South Korea
USA accounted for over 40% of global Complementary and Alternative Medicine for Anti-Aging & Longevity Market demand in 2021.
The United Kingdom market for Complementary and Alternative Medicine for Anti-Aging & Longevity Market is projected to expand at a CAGR of around 22.8% from 2022 to 2032.
1. Executive Summary | Complementary and Alternative Medicine for Anti-Aging & Longetivity Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyers
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Intervention
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Intervention, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Intervention, 2022 to 2032
5.3.1. Traditional Alternative Medicine/Botanicals
5.3.1.1. Ayurveda
5.3.1.2. Apitherapy
5.3.1.3. Bach Flower Therapy
5.3.1.4. Naturopathic Medicine
5.3.1.5. Traditional Chinese Medicine
5.3.1.6. Traditional Korean Medicine
5.3.1.7. Traditional Japanese Medicine
5.3.1.8. Traditional Mongolian Medicine
5.3.1.9. Traditional Tibetan Medicine
5.3.1.10. Zang Fu Theory
5.3.2. Mind Healing
5.3.2.1. Autosuggestion
5.3.2.2. Hypnotherapy
5.3.2.3. Neuro-linguistic Programming
5.3.2.4. Self-hypnosis
5.3.2.5. Other Mind Healing
5.3.2.6. Auriculotherapy
5.3.3. Body Healing
5.3.3.1. Acupressure
5.3.3.2. Acupuncture
5.3.3.3. Alexander Technique
5.3.3.4. Auriculotherapy
5.3.3.5. Other Body Healing
5.3.4. External Energy
5.3.4.1. Magnetic Therapy
5.3.4.2. Radionics
5.3.4.3. Reiki
5.3.4.4. Therapeutic Touch
5.3.4.5. Chakra Healing
5.3.5. Sensory Healing
5.3.5.1. Aromatherapy
5.3.5.2. Music therapy
5.3.5.3. Sonopuncture
5.3.5.4. Sound Therapy
5.4. Y-o-Y Growth Trend Analysis By Intervention, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Intervention, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Method
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution Method, 2017 to 2021
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution Method, 2022 to 2032
6.3.1. Direct Sales
6.3.2. E-sales
6.3.3. Distance Correspondence
6.4. Y-o-Y Growth Trend Analysis By Distribution Method, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By Distribution Method, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2017 to 2021
7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2022 to 2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021
8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Intervention
8.2.3. By Distribution Method
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Intervention
8.3.3. By Distribution Method
8.4. Key Takeaways
9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Intervention
9.2.3. By Distribution Method
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Intervention
9.3.3. By Distribution Method
9.4. Key Takeaways
10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Russia
10.2.1.7. Rest of Europe
10.2.2. By Intervention
10.2.3. By Distribution Method
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Intervention
10.3.3. By Distribution Method
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. India
11.2.1.4. South Korea
11.2.1.5. Australia
11.2.1.6. Rest of Asia Pacific
11.2.2. By Intervention
11.2.3. By Distribution Method
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Intervention
11.3.3. By Distribution Method
11.4. Key Takeaways
12. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. South Africa
12.2.1.2. Saudi Arabia
12.2.1.3. United Arab Emirates(UAE)
12.2.1.4. Israel
12.2.1.5. Rest of Middle East and Africa(MEA)
12.2.2. By Intervention
12.2.3. By Distribution Method
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Intervention
12.3.3. By Distribution Method
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. USA
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Intervention
13.1.2.2. By Distribution Method
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Intervention
13.2.2.2. By Distribution Method
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Intervention
13.3.2.2. By Distribution Method
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Intervention
13.4.2.2. By Distribution Method
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Intervention
13.5.2.2. By Distribution Method
13.6. United Kingdom
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Intervention
13.6.2.2. By Distribution Method
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Intervention
13.7.2.2. By Distribution Method
13.8. Spain
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Intervention
13.8.2.2. By Distribution Method
13.9. Italy
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Intervention
13.9.2.2. By Distribution Method
13.10. Russia
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Intervention
13.10.2.2. By Distribution Method
13.11. China
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Intervention
13.11.2.2. By Distribution Method
13.12. Japan
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Intervention
13.12.2.2. By Distribution Method
13.13. India
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Intervention
13.13.2.2. By Distribution Method
13.14. South Korea
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Intervention
13.14.2.2. By Distribution Method
13.15. Australia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Intervention
13.15.2.2. By Distribution Method
13.16. South Africa
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Intervention
13.16.2.2. By Distribution Method
13.17. Saudi Arabia
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Intervention
13.17.2.2. By Distribution Method
13.18. United Arab Emirates(UAE)
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2021
13.18.2.1. By Intervention
13.18.2.2. By Distribution Method
13.19. Israel
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2021
13.19.2.1. By Intervention
13.19.2.2. By Distribution Method
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Intervention
14.3.3. By Distribution Method
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Columbia Nutritional
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.1.5.2. Product Strategy
15.1.1.5.3. Channel Strategy
15.1.2. Herbal Hills
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.2.5.2. Product Strategy
15.1.2.5.3. Channel Strategy
15.1.3. Yoga Tree Studios, Inc.
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.3.5.2. Product Strategy
15.1.3.5.3. Channel Strategy
15.1.4. Helio USA Inc.
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.4.5.2. Product Strategy
15.1.4.5.3. Channel Strategy
15.1.5. NatureKue
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.5.5.2. Product Strategy
15.1.5.5.3. Channel Strategy
15.1.6. Nordic Nutraceuticals
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.6.5.2. Product Strategy
15.1.6.5.3. Channel Strategy
15.1.7. Pure Encapsulations, LLC.
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.7.5.2. Product Strategy
15.1.7.5.3. Channel Strategy
15.1.8. The Healing Company Ltd.
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.8.5.2. Product Strategy
15.1.8.5.3. Channel Strategy
15.1.9. Quantum-Touch
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.9.5.2. Product Strategy
15.1.9.5.3. Channel Strategy
15.1.10. Amrita Ayurveda & Yoga
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
15.1.10.5.2. Product Strategy
15.1.10.5.3. Channel Strategy
15.1.11. Sheng Chang Pharmaceutical Company
15.1.11.1. Overview
15.1.11.2. Product Portfolio
15.1.11.3. Profitability by Market Segments
15.1.11.4. Sales Footprint
15.1.11.5. Strategy Overview
15.1.11.5.1. Marketing Strategy
15.1.11.5.2. Product Strategy
15.1.11.5.3. Channel Strategy
15.1.12. LKK Health Products Group Limited
15.1.12.1. Overview
15.1.12.2. Product Portfolio
15.1.12.3. Profitability by Market Segments
15.1.12.4. Sales Footprint
15.1.12.5. Strategy Overview
15.1.12.5.1. Marketing Strategy
15.1.12.5.2. Product Strategy
15.1.12.5.3. Channel Strategy
15.1.13. Herb Pharm
15.1.13.1. Overview
15.1.13.2. Product Portfolio
15.1.13.3. Profitability by Market Segments
15.1.13.4. Sales Footprint
15.1.13.5. Strategy Overview
15.1.13.5.1. Marketing Strategy
15.1.13.5.2. Product Strategy
15.1.13.5.3. Channel Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Explore Healthcare Insights
View Reports